BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27067438)

  • 1. Circulating levels of TNF-related apoptosis inducing-ligand are decreased in patients with large adult-type granulosa cell tumors-implications for therapeutic potential.
    Färkkilä A; Zauli G; Haltia UM; Pihlajoki M; Unkila-Kallio L; Secchiero P; Heikinheimo M
    Tumour Biol; 2016 Sep; 37(9):11909-11916. PubMed ID: 27067438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATA4 protects granulosa cell tumors from TRAIL-induced apoptosis.
    Kyrönlahti A; Kauppinen M; Lind E; Unkila-Kallio L; Butzow R; Klefström J; Wilson DB; Anttonen M; Heikinheimo M
    Endocr Relat Cancer; 2010 Sep; 17(3):709-17. PubMed ID: 20554787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Müllerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumors.
    Haltia UM; Hallamaa M; Tapper J; Hynninen J; Alfthan H; Kalra B; Ritvos O; Heikinheimo M; Unkila-Kallio L; Perheentupa A; Färkkilä A
    Gynecol Oncol; 2017 Jan; 144(1):83-89. PubMed ID: 27871721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical utility of serum anti-Müllerian hormone in the follow-up of ovarian adult-type granulosa cell tumors--A comparative study with inhibin B.
    Färkkilä A; Koskela S; Bryk S; Alfthan H; Bützow R; Leminen A; Puistola U; Tapanainen JS; Heikinheimo M; Anttonen M; Unkila-Kallio L
    Int J Cancer; 2015 Oct; 137(7):1661-71. PubMed ID: 25808251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procaspase-Activating Compound-1 Synergizes with TRAIL to Induce Apoptosis in Established Granulosa Cell Tumor Cell Line (KGN) and Explanted Patient Granulosa Cell Tumor Cells In Vitro.
    Crosley P; Farkkila A; Jenner AL; Burlot C; Cardinal O; Potts KG; Agopsowicz K; Pihlajoki M; Heikinheimo M; Craig M; Fu Y; Hitt MM
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXL2 and TERT promoter mutation detection in circulating tumor DNA of adult granulosa cell tumors as biomarker for disease monitoring.
    Groeneweg JW; Roze JF; Peters EDJ; Sereno F; Brink AGJ; Paijens ST; Nijman HW; van Meurs HS; van Lonkhuijzen LRCW; Piek JMJ; Lok CAR; Monroe GR; van Haaften GW; Zweemer RP
    Gynecol Oncol; 2021 Aug; 162(2):413-420. PubMed ID: 34083028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary.
    Da Cruz Paula A; da Silva EM; Segura SE; Pareja F; Bi R; Selenica P; Kim SH; Ferrando L; Vahdatinia M; Soslow RA; Vidal A; Gatius S; Przybycin CG; Abu-Rustum NR; Matias-Guiu X; Rubin BP; Reis-Filho JS; DeLair DF; Weigelt B
    Mod Pathol; 2020 Aug; 33(8):1606-1617. PubMed ID: 32203090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXL2 402C>G Mutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult-Type Granulosa Cell Tumor.
    Färkkilä A; McConechy MK; Yang W; Talhouk A; Ng Y; Lum A; Morin RD; Bushell K; Riska A; McAlpine JN; Gilks CB; Unkila-Kallio L; Anttonen M; Huntsman DG
    J Mol Diagn; 2017 Jan; 19(1):126-136. PubMed ID: 27810330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Profiling of FSH and Estradiol in Ovarian Granulosa Cell Tumors.
    Haltia UM; Pihlajoki M; Andersson N; Mäkinen L; Tapper J; Cervera A; Horlings HM; Turpeinen U; Anttonen M; Bützow R; Unkila-Kallio L; Carpén O; Wilson DB; Heikinheimo M; Färkkilä A
    J Endocr Soc; 2020 Apr; 4(4):bvaa034. PubMed ID: 32309755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse correlation between circulating levels of TNF-related apoptosis-inducing ligand and 17β-estradiol.
    Zauli G; Tisato V; Melloni E; Volpato S; Cervellati C; Bonaccorsi G; Radillo O; Marci R; Secchiero P
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E659-64. PubMed ID: 24446659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.
    Vigneswaran N; Baucum DC; Wu J; Lou Y; Bouquot J; Muller S; Zacharias W
    BMC Cancer; 2007 Jun; 7():108. PubMed ID: 17592646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic analysis of stage 1 versus advanced adult granulosa cell tumors.
    Alexiadis M; Chu S; Leung D; Gould JA; Jobling T; Fuller PJ
    Oncotarget; 2016 Mar; 7(12):14207-19. PubMed ID: 26893359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum vascular endothelial growth factor A (VEGF) is elevated in patients with ovarian granulosa cell tumor (GCT), and VEGF inhibition by bevacizumab induces apoptosis in GCT in vitro.
    Färkkilä A; Pihlajoki M; Tauriala H; Bützow R; Leminen A; Unkila-Kallio L; Heikinheimo M; Anttonen M
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E1973-81. PubMed ID: 21994955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis.
    Michowitz Y; Goldstein E; Roth A; Afek A; Abashidze A; Ben Gal Y; Keren G; George J
    J Am Coll Cardiol; 2005 Apr; 45(7):1018-24. PubMed ID: 15808757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer.
    Horak P; Pils D; Haller G; Pribill I; Roessler M; Tomek S; Horvat R; Zeillinger R; Zielinski C; Krainer M
    Mol Cancer Res; 2005 Jun; 3(6):335-43. PubMed ID: 15972852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis and expression of protein TRAIL in granulosa cells of rats with polycystic ovarian syndrome.
    Zhang J; Zhu G; Wang X; Xu B; Hu L
    J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):311-4. PubMed ID: 17641850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
    Färkkilä A; Anttonen M; Pociuviene J; Leminen A; Butzow R; Heikinheimo M; Unkila-Kallio L
    Eur J Endocrinol; 2011 Jan; 164(1):115-22. PubMed ID: 21041381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients.
    Tanaka H; Ito T; Kyo T; Kimura A
    Eur J Haematol; 2007 May; 78(5):389-98. PubMed ID: 17432976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary.
    Kommoss S; Gilks CB; Penzel R; Herpel E; Mackenzie R; Huntsman D; Schirmacher P; Anglesio M; Schmidt D; Kommoss F
    Histopathology; 2014 Feb; 64(3):380-8. PubMed ID: 24192202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult Granulosa Cell Tumor With High-grade Transformation: Report of a Series With FOXL2 Mutation Analysis.
    Fashedemi Y; Coutts M; Wise O; Bonhomme B; Baker G; Kelly PJ; Soubeyran I; Catherwood MA; Croce S; McCluggage WG
    Am J Surg Pathol; 2019 Sep; 43(9):1229-1238. PubMed ID: 31162286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.